Multi-arm PEG-azido Derivative for Targeted Drug Conjugation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing multi-arm polyethylene glycol derivatives lack azido groups as active end groups, limiting their applications in peptide synthesis and drug delivery, particularly in controlled release and targeting administration.
Innovation Solution
A multi-arm polyethylene glycol-azido derivative is developed with a specific structure, incorporating azido end groups and various active end groups, allowing for conjugation with proteins, peptides, or drugs, enhancing targeting ability and drug efficacy while reducing toxicity.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Adaptability or versatility
If multi-arm polyethylene glycol derivatives are used without azido groups, then the structure is simple and easy to manufacture, but the application range is limited and cannot be used for peptide synthesis or targeted drug delivery
Solution Approach 1:
The patent introduces azido groups specifically at the terminal positions of the multi-arm polyethylene glycol chains, while maintaining the core PEG structure. This localized functionalization provides the necessary reactivity for peptide synthesis and drug delivery applications without fundamentally altering the entire molecular architecture, thus balancing versatility improvement with structural simplicity
Solution Approach 2:
The patent creates a composite molecular structure combining the biocompatible polyethylene glycol backbone with reactive azido functional groups at the terminals. This composite approach integrates the advantages of both components: the solubility and biocompatibility of PEG with the high reactivity of azido groups toward alkynes and other functional groups, expanding application possibilities without sacrificing the ease of handling the base polymer
2Ease of manufacture
If azido groups are introduced at terminal groups only, then the synthesis is straightforward, but the functional groups cannot be introduced into other active groups on the polymer chain
Solution Approach 1:
The patent employs terminal-specific functionalization where azido groups are introduced exclusively at the terminal positions of the multi-arm PEG structure through controlled chemical reactions. This localized approach maintains straightforward synthesis procedures while the multi-arm architecture itself provides multiple terminal sites, effectively distributing functional groups throughout the molecule without requiring complex modification of the polymer backbone
Solution Approach 2:
The multi-arm structure naturally segments the polymer into multiple terminal regions, each capable of independent functionalization. This segmentation allows the same terminal functionalization chemistry to be applied across multiple sites simultaneously, achieving distributed functionality through a simplified single-step process rather than requiring sequential modification of different chain positions
3Object-affected harmful factors
If conventional PEG derivatives are used, then the biocompatibility is good, but the targeting ability and drug release control are insufficient
Solution Approach 1:
The patent modifies the terminal functional groups of the PEG derivative from inert hydroxyl groups to highly reactive azido groups. This parameter change in chemical reactivity enables subsequent conjugation with targeting moieties and drugs through click chemistry or other azido-specific reactions, while the bulk PEG structure remains unchanged to preserve biocompatibility and low toxicity characteristics
Solution Approach 2:
The azido groups serve as intermediary functional groups that facilitate the conjugation between the biocompatible PEG backbone and therapeutic agents or targeting ligands. These azido intermediaries enable efficient coupling reactions with alkyne-containing compounds, allowing the assembly of complex drug delivery systems while maintaining the benign properties of the original PEG structure
Data Source
AI summary
Provided is a multi-arm polyethylene glycol-azido derivative of general formula I, wherein R is a central molecule, which is selected from a polyhydroxy structure, a polyamino structure or a polycarboxyl structure; n is the number of branches or arms, n≧3; PEG is the same or different -(CH2CH2O)m-, the average value of m being an integer from 3 to 250; X is a linking group of an azido end group; k is the number of the branches having the azido end group; F is selected from the group consisting of amino, carboxyl, sulfhydryl, ester group, maleic imide group and acrylic group; and Y is a linking group of an end group F.